新型冠狀病毒

Surge in colds and flu boosts medicine sales
感冒和流感激增提振非處方藥銷售

Demand for over-the-counter remedies rises as rebound in seasonal illnesses combines with Covid-19
季節性疾病的反彈與新冠肺炎相結合,導致對非處方藥物的需求有所上升。

A resurgence of colds and flu has combined with Covid-19 to boost sales of over-the-counter medicines, providing a boost for consumer health groups that produce remedies for coughing and sneezing populations.

感冒和流感捲土重來,再加上新冠肺炎(Covid-19),提振了非處方藥的銷售,提振了爲咳嗽和打噴嚏人羣生產藥物的消費者健康集團。

您已閱讀5%(272字),剩餘95%(5488字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×